Related Experiment Videos
PSA as a marker for prostate cancer: a critical review
1Department of Nuclear Medicine, St Vincent's Hospital, Dublin, Ireland.
Annals of Clinical Biochemistry
|November 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A zinc phthalocyanine-benzoperylenetriimide conjugate for solvent dependent ultrafast energy vs. electron transfer.
Chemical communications (Cambridge, England)·2019
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).
European journal of cancer (Oxford, England : 1990)·2017
Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
International journal of cancer·2016
Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells.
British journal of cancer·2015
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
International journal of cancer·2013
First report of daratumumab interference in urine immunofixation electrophoresis confirmed by the HYDRASHIFT 2/4 Daratumumab assay.
Annals of clinical biochemistry·2026
Pseudo-hypouricemia in four patients with lymphoma and one patient with breast cancer: Interference analysis and elimination.
Annals of clinical biochemistry·2026
Preparation and Evaluation of In-House Multi-Analyte Quality Control Materials for ANA, Anti-dsDNA, and Autoantibody Profile Assays.
Annals of clinical biochemistry·2026
Untargeted LC-MS/MS profiling identifies ST18 as a novel serum marker for T2DM-associated depression.
Annals of clinical biochemistry·2026
Bayesian secondary reanalysis of published aggregate data on circulating tumor DNA for molecular residual disease detection across cancer types.
Annals of clinical biochemistry·2026
Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.
Journal of the National Cancer Institute·2026
Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.
Journal of the National Cancer Institute·2026
Survival outcomes of expansile versus infiltrative subtype in primary mucinous ovarian carcinomas: A retrospective study in Thailand.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Risk factors for local recurrence and metastasis of eyelid sebaceous carcinoma after complete excision: A large cohort study in Japan.
Indian journal of ophthalmology·2026